X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Diabetes Metabolic Syndrome and Obesity

期刊標題檢索 DIABET METAB SY 最新評論: Do I need to pay in advance? (2023-09-12)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Diabetes Metabolic Syndrome and Obesity]您好,您是該頁面的第 36151 位訪客。

期刊簡介
期刊名稱Diabetes Metabolic Syndrome and Obesity Diabetes Metabolic Syndrome and Obesity
LetPub Score
6.2
50 ratings
Rate

Reputation
7.2

Influence
5.2

Speed
7.1

期刊簡稱DIABET METAB SYND OB
ISSN1178-7007
h-index35
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.900.8350.997
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Internal Medicine
Q244 / 167
Category: Medicine
Subcategory: Pharmacology
Q2124 / 313

自引率 (2023-2024)3.60%自引率趨勢
掲載範囲
An international, peer-reviewed, open access, online journal. The journal is committed to the rapid publication of the latest laboratory and clinical findings in the fields of diabetes, metabolic syndrome and obesity research. Original research, review, case reports, hypothesis formation, expert opinion and commentaries are all considered for publication.
官方網站https://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal
在線稿件提交https://www.dovepress.com/submit_step_1.php
開放訪問Yes
出版商Dove Medical Press Ltd.
主題領域Pharmacology, Toxicology and Pharmaceutics
出版國/地區New Zealand
發行頻率
創刊年0
每年文章數337每年文章數趨勢
黃金OA百分比98.74%
OA Related Info
APC: Yes( USD3300; )
APC waiver:Check Notes
Other charges: No
Keywords: diabetes、obesity、metabolic syndrome
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ENDOCRINOLOGY & METABOLISMSCIEQ397/186
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1178-7007%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 16 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Diabetes Metabolic Syndrome and Obesity】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    VaccinesH-index: 0

    CiteScore: 8.90
    DRUGS IN R&DH-index: 39

    CiteScore: 5.10
    INDIAN JOURNAL OF PHARMACOLOGYH-index: 0

    CiteScore: 4.00
    Contemporary Clinical Trials CommunicationsH-index: 0

    CiteScore: 2.70
    BULLETIN OF PHARMACEUTICAL SCIENCESH-index: 0

    CiteScore: 0.40
    Journal of Jilin University Medicine EditionH-index: 0

    CiteScore: 0.20
    Antiviral Chemistry and ChemotherapyH-index: 0

    CiteScore: 5.20
    Current Pharmacogenomics and Personalized MedicineH-index: 0

    CiteScore: 0.40
    Advances in PharmacologyH-index: 0

    CiteScore: 9.10
    Chinese Journal of Cancer BiotherapyH-index: 0

    CiteScore: 0.20
    學科內最受檢索的期刊 頁面查看次數
    Contemporary Clinical Trials Communications243019
    Vaccines49894
    DRUGS IN R&D12549
    INDIAN JOURNAL OF PHARMACOLOGY9266
    BULLETIN OF PHARMACEUTICAL SCIENCES8092
    Current Pharmacogenomics and Personalized Medicine3389
    Biomedical and Pharmacology Journal3222
    Advances in Pharmacology3072
    Infectious Disorders - Drug Targets2305
    Anti-Infective Agents2208
  •  

    Diabetes Metabolic Syndrome and Obesity Diabetes Metabolic Syndrome and Obesity
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Diabetes Metabolic Syndrome and Obesity] 的評論撰寫評論
作者: grace萍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-12 09:08:40 評論於
Do I need to pay in advance?
(0) 讚! | grace萍

作者: 呵呵呵


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2023-08-31 10:53:17 評論於
The review process was very fast. Three weeks after submission, reviewers were assigned. Two reviewers were invited, and their comments were very professional. After minor revisions submitted in two weeks, the editorial assistant raised a few questions. The manuscript went through four more rounds of revisions over the course of a month, showing great attention to detail by the assistant. Thumbs up! Finally, the paper was accepted for publication, taking about three months from submission to acceptance. Best wishes to all researchers for their success!
(2) 讚! | 呵呵呵

作者: hmily1527


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-12 10:11:34 評論於
Ah, what is the subject of the article? How far along is it in the peer-review process? I just submitted it and suddenly became afraid.
(0) 讚! | hmily1527

作者: apoptoxin4869


領域: 医学
審稿時間: 6.0 month(s)
結果: 拒稿


撰寫評論

2022-07-11 09:05:01 評論於
The submission was rejected after more than a month, with the reason being unable to find enough peer reviewers... It's quite unreasonable.
(0) 讚! | apoptoxin4869

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Diabetes Metabolic Syndrome and Obesity] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*